Arch Biopartners Inc.
$5,407,235.00 CAD
≈ 70 Canadians' average pay for a year
- Program
- SIF Stream 1- R&D
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- September 1, 2020 – March 31, 2022
- Reference
- ic:033-2020-2021-Q3-513415
Published purpose
This project is to advance a lead therapeutic drug candidate through Phase II clinical trials to treat severe cases of COVID-19, specifically in the lungs, kidney and liver.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions